巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Lixte Biotechnology Holdings

    LIXT
    0.753
    0.070
    8.71%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Lixte Biotechnology Holdings - 延遲價格・最後更新於 26/05 12:14
    最高位
    0.818
    最低位
    0.753
    開市價
    --
    前收市價
    0.825
    成交量(千)
    8.95
    成交額(百萬)
    0.07
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    12.53
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    4.950 - 0.720
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Lixte Biotechnology Holdings
    證券代碼
    LIXT.US
    所屬板塊
    Biotechnology
    公司業務
    Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors.
    發行量
    13746593
    公司總部
    680 East Colorado Boulevard, Suite 180
    公司網址
    https://www.lixte.com
    公司電話
    +1 631 830-7092
    暫無內容

    關於

    Lixte Biotechnology Holdings(LIXT.US)所屬的行業板塊為Biotechnology。
    Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors.
    詳細公司背景可參考: https://www.lixte.com